ArticleInternational urology and nephrology2024

Comment on "The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease".

I-Wen Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.